Skip to main content

Table 7 The clinical characteristics of patients in the two risk groups in TCGA-UM cohort (n = 80)

From: Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma

Clinical characteristics Low-risk group (n = 31) High-risk group (n = 49)
Gender   
Male 18 (51.4) 27 (55.1)
Female 13 (48.6) 22 (44.9)
T staging   
T2 8 (25.8) 6 (12.3)
T3 14 (45.2) 18 (36.7)
T4 9 (29.0) 25 (51.0)
M staging   
M0 21 (67.7) 30 (61.2)
M1 - 4 (8.2)
Unknown 10 (32.3) 15 (30.6)
N staging   
N0 21 (67.7) 31 (63.3)
Unknown 10 (32.3) 18 (36.7)
TMN stages   
II 20 (64.5) 19 (38.8)
III 11 (35.5) 25 (51.0)
IV - 4 (8.2)
Unknown - 1 (2.0)